Evidence map›Paper›PMID 29237835›Full record

ArticleJournal of virology2018

HLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/E.

Takayuki Chikata, Giang Van Tran, Hayato Murakoshi, Tomohiro Akahoshi, Ying Qi, Vivek Naranbhai, Nozomi Kuse, Yoshiko Tamura, Madoka Koyanagi, Sachiko Sakai and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Control of HIV-1 Replication by CD8Journal of virology · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 4 countries.

Takayuki Chikata *Center for AIDS Research, Kumamoto University, Kumamoto, Japan.
Giang Van Tran *Center for AIDS Research, Kumamoto University, Kumamoto, Japan.
Hayato MurakoshiCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Tomohiro AkahoshiCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Ying QiCancer and Inflammation Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Vivek NaranbhaiCancer and Inflammation Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Nozomi KuseCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Yoshiko TamuraCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Madoka KoyanagiCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Sachiko SakaiCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Dung Hoai NguyenNational Hospital of Tropical Diseases, Dong Da District, Hanoi, Vietnam.
Dung Thi NguyenNational Hospital of Tropical Diseases, Dong Da District, Hanoi, Vietnam.
Ha Thu NguyenNational Hospital of Tropical Diseases, Dong Da District, Hanoi, Vietnam.
Trung Vu NguyenNational Hospital of Tropical Diseases, Dong Da District, Hanoi, Vietnam.
Shinichi OkaCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Maureen P MartinCancer and Inflammation Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Mary CarringtonCancer and Inflammation Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Keiko SakaiCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Kinh Van NguyenNational Hospital of Tropical Diseases, Dong Da District, Hanoi, Vietnam.
Masafumi TakiguchiCenter for AIDS Research, Kumamoto University, Kumamoto, Japan masafumi@kumamoto-u.ac.jp.
Kumamoto University · JPHospital for Tropical Diseases · VNFrederick National Laboratory for Cancer Research · USLeidos (United States) · USRagon Institute of MGH, MIT and Harvard · US

Funding

CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

HIV-1-specific cytotoxic T cells (CTLs) play an important role in the control of HIV-1 subtype B or C infection. However, the role of CTLs in HIV-1 subtype A/E infection still remains unclear. Here we investigated the association of HLA class I alleles with clinical outcomes in treatment-naive Vietnamese infected with subtype A/E virus. We found that HLA-C*12:02 was significantly associated with lower plasma viral loads (pVL) and higher CD4 counts and that the HLA-A*29:01-B*07:05-C*15:05 haplotype was significantly associated with higher pVL and lower CD4 counts than those for individuals without these respective genotypes. Nine Pol and three Nef mutations were associated with at least one HLA allele in the HLA-A*29:01-B*07:05-C*15:05 haplotype, with a strong negative correlation between the number of HLA-associated Pol mutations and CD4 count as well as a positive correlation with pVL for individuals with these HLA alleles. The results suggest that the accumulation of mutations selected by CTLs restricted by these HLA alleles affects HIV control.

Indexed as

Genetic FitnessAdultAllelesAsian PeopleCD4 Lymphocyte CountGenes, MHC Class IGenotypeHaplotypesHIV-1HIV InfectionsHLA-A AntigensHLA-B7 AntigenHLA-C AntigensHost-Pathogen InteractionsHumansMutationHLA-A29 antigenHLA-A AntigensHLA-B*07 antigenHLA-B7 AntigenHLA-C*12 antigenHLA-C*15 antigenHLA-C Antigenspol Gene Products, Human Immunodeficiency Virusclinical outcomedeleterious alleleHIV-1HLA-associated mutationHLA class Iprotective allelesubtype A/EVietnam

Identifiers

PMID29237835
PMCPMC5809730
OpenAlexW2773359593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.